Replies to post #6214 on Generex Biotechnology Corp. (fka GNBTQ)

[DigitalTradz]

We debated the O/S elsewhere and came up with this. I think the math can be figured from one of the 8Ks.

There are around 1.2M issued and outstanding. That is the public float.

And there are 2.45M authorized.

So before they can issue shares to Emmaus, they have to have the shareholders vote to increase the amount of authorized.

Yes it will be interesting. The company has to come up with $6M cash to complete the Emmaus deal. From where? The balance as we know will be in new shares issued going straight to Emmaus. I think there is a restriction of some type on them though so that they won't hit the market right away.

I'm just a spectator in the whole thing but have followed the company for years.

Yes, it will be interesting to whatch.